Literature DB >> 8410988

Novel antagonists of 5-HT3 receptors. Synthesis and biological evaluation of piperazinylquinoxaline derivatives.

A Monge1, J A Palop, J C Del Castillo, J M Calderó, J Roca, G Romero, J Del Río, B Lasheras.   

Abstract

A series of piperazinylquinoxalines has been synthesized and studied as 5-HT3 receptor antagonists in different preparations. Antagonism to 5-HT in the longitudinal muscle of the guinea pig ileum was particularly prominent in cyanoquinoxaline derivatives with an alkyl substitutuent on the piperazine moiety. The pA2 of some selected compounds against the 5-HT3 agonist 2-methyl-5HT in the guinea pig ileum was in the range of tropisetron or ondansetron, and one of them, 7e, was more potent than these reference compounds by approximately 2 or 3 orders of magnitude. However, these compounds were markedly less potent than either tropisetron or ondansetron as displacers of 3H-BRL 43694 binding to rat cortical membranes or as antagonists of the Bezold-Jarisch reflex in rats. Piperazinylcyanoquinoxalines represent a new class of 5-HT3 antagonists with a selective effect on guinea pig peripheral receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8410988     DOI: 10.1021/jm00071a005

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Clozapine's antipsychotic effects do not depend on blockade of 5-HT3 receptors.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1999-05       Impact factor: 3.996

Review 2.  Merged Tacrine-Based, Multitarget-Directed Acetylcholinesterase Inhibitors 2015-Present: Synthesis and Biological Activity.

Authors:  Todd J Eckroat; Danielle L Manross; Seth C Cowan
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

3.  Aerobic Cytotoxicity of Aromatic N-Oxides: The Role of NAD(P)H:Quinone Oxidoreductase (NQO1).

Authors:  Aušra Nemeikaitė-Čėnienė; Jonas Šarlauskas; Lina Misevičienė; Audronė Marozienė; Violeta Jonušienė; Mindaugas Lesanavičius; Narimantas Čėnas
Journal:  Int J Mol Sci       Date:  2020-11-19       Impact factor: 5.923

4.  5-HT3 receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders.

Authors:  Shvetank Bhatt; Thangaraj Devadoss; Santhepete Nanjundaiah Manjula; Jayaraman Rajangam
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

5.  3-[2-(3-Phenyl-2-oxo-1,2-di-hydro-quin-oxalin-1-yl)eth-yl]-1,3-oxazolidin-2-one.

Authors:  Ballo Daouda; Mouhamadou Lamine Doumbia; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-05

6.  Structure-activity relationships of quinoxaline-based 5-HT3A and 5-HT3AB receptor-selective ligands.

Authors:  Andrew J Thompson; Mark H P Verheij; Jacqueline E van Muijlwijk-Koezen; Sarah C R Lummis; Rob Leurs; Iwan J P de Esch
Journal:  ChemMedChem       Date:  2013-05-02       Impact factor: 3.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.